...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit
【24h】

Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit

机译:急性髓性白血病患者的成果和变化患者接受诱导化疗,他们转移到重症监护病房

获取原文
获取原文并翻译 | 示例
           

摘要

Highlights ? AML patients transferred to the ICU have a guarded prognosis. ? Code status can dictate the extent of aggressive ICU care. ? Code status changed for 58% of patients transferred to the ICU. ? Full Code and DNR patients had better survival compared to comfort care. Abstract Patients with Acute Myeloid Leukemia (AML) have compromised marrow function and chemotherapy causes further suppression. As a result complications are frequent, and patients may require admission to the intensive care unit (ICU). How codes status changes when these events occur and how those changes influence outcome are largely unknown. Outcomes for adult patients with AML, undergoing induction chemotherapy, and transferred to the ICU between January 2000 and December 2013 were analyzed. 94 patients were included. Median survival was 1.3 months. At 3 and 6 months overall survival (OS) was 27% and 18% respectively. Respiratory failure was the most common reason for transfer to ICU (88%), with 63% requiring mechanical ventilation at transfer. Other reasons included: cardiac arrest (18%), septic shock (17%), hypotension (9%), and acute renal failure (9%). The most frequent interventions were mechanical ventilation in 85%, vasopressors in 62%, and hemodialysis in 30%. Following transfer 55 patients (58%) had a change in code status. Overall, 46 patients (49%) changed from Full Code (FC) to Comfort Care (CC), 7 (7%) from FC to Do Not Resuscitate (DNR), and 2 (2%) from DNR to CC. For the entire cohort, ICU mortality (IM) was 61% and hospital mortality (HM) was 71%. For FC or DNR patients, IM was 30% and HM was 41%. For CC patients, IM was 90% and HM was 100%. Overall, 27 patients (29%) survived to discharge. Of those discharged, 22 (81%) were alive at 3 months and 17 (63%) were alive at 6 months. In conclusion, patients that required ICU admission during induction chemotherapy have a poor prognosis. Code status changed during the ICU stay for the majority of patients and always to a less aggressive status.
机译:强调 ? AML患者转移到ICU的守卫预后。还代码状态可以决定激进的ICU关心程度。还代码状态改为58%的患者转移到ICU。还与舒适性相比,全码和DNR患者的存活率更好。摘要患有急性髓性白血病(AML)的患者具有损害的骨髓功能和化疗导致进一步抑制。结果,并发症频繁,患者可能需要录取重症监护单元(ICU)。当这些事件发生时,代码状态如何以及这些事件的变化如何影响结果是很大程度的。分析了成年患者的成果,患有AML,接受诱导化疗,并于2013年1月至12月转移到ICU转移到ICU。包括94名患者。中位生存率为1.3个月。在3和6个月,总生存率(OS)分别为27%和18%。呼吸衰竭是转移到ICU(88%)的最常见原因,63%需要转移机械通风。包括其他原因:心脏骤停(18%),化脓性休克(17%),低血压(9%)和急性肾功能衰竭(9%)。最常见的干预措施是85%的机械通风,血管加压料62%,血液透析30%。转让55名患者(58%)的代码状态发生变化。总体而言,46名患者(49%)从全码(FC)变为舒适护理(CC),来自Fc的7(7%),不要从DNR到CC重生(DNR),2(2%)。对于整个队列,ICU死亡率(IM)为61%,医院死亡率(HM)为71%。对于FC或DNR患者,IM为30%,HM为41%。对于CC患者,IM为90%,HM为100%。总体而言,27名患者(29%)存放到出院。其中排出的那些,22(81%)在3个月内活着,17例(63%)在6个月内活着。总之,在感应化疗期间需要ICU入院的患者具有差的预后差。在ICU期间改变了代码状态,留在大多数患者中,并始终处于较少的侵略状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号